{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:01:05Z","timestamp":1791115265332,"version":"4.1.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":944,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1111\/bjd.12105","type":"journal-article","created":{"date-parts":[[2012,10,27]],"date-time":"2012-10-27T11:11:09Z","timestamp":1351336269000},"page":"311-317","source":"Crossref","is-referenced-by-count":56,"title":["Impact of Toll-like receptor-4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa"],"prefix":"10.1093","volume":"168","author":[{"given":"A.","family":"Savva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Damoraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kotsaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Giatrakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Grech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Katoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Papadavid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,1,30]]},"reference":[{"key":"10.1111\/bjd.12105-BIB1|cit1","first-page":"15","article-title":"Hidradenitis suppurativa","volume":"28","author":"Dandy","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1111\/bjd.12105-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.lpm.2010.08.003","article-title":"Hidradenitis suppurativa","volume":"39","author":"Revuz","year":"2010","journal-title":"Presse Med"},{"key":"10.1111\/bjd.12105-BIB3|cit3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"The prevalence of hidradenitis suppurativa and its potential precursor lesions","volume":"39","author":"Jemec","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12105-BIB4|cit4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2340\/00015555-0866","article-title":"Psychophysical aspects of hidradenitis suppurativa","volume":"90","author":"Matusiak","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.12105-BIB5|cit5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"Von der Werth","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12105-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2011.08.047","article-title":"Pathogenesis and pharmacotherapy of hidradenitis suppurativa","volume":"672","author":"Nazary","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/bjd.12105-BIB7|cit7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2133.2006.07556.x","article-title":"Altered innate and adaptive immune responses in patients with hidradenitis suppurativa","volume":"156","author":"Giamarellos-Bourboulis","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12105-BIB8|cit8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2133.2009.09430.x","article-title":"Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study","volume":"162","author":"Van der Zee","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12105-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"Van der Zee","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12105-BIB10|cit10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1365-2133.2007.08372.x","article-title":"An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa","volume":"158","author":"Giamarellos-Bournoulis","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12105-BIB11|cit11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2133.2007.08332.x","article-title":"Long-term efficacy of a single course of infliximab in hidradenitis suppurativa","volume":"158","author":"Mekkes","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12105-BIB12|cit12","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jaad.2008.11.898","article-title":"A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa","volume":"60","author":"Lee","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12105-BIB13|cit13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2009.06.050","article-title":"Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial","volume":"62","author":"Grant","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12105-BIB14|cit14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity","volume":"1","author":"Medzitov","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/bjd.12105-BIB15|cit15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/76048","article-title":"TLR4 mutations are associated with endotoxin hyporesponsiveness in humans","volume":"25","author":"Arbour","year":"2000","journal-title":"Nat Genet"},{"key":"10.1111\/bjd.12105-BIB16|cit16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1399-0039.1998.tb03056.x","article-title":"Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter","volume":"52","author":"Uglialoro","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1111\/bjd.12105-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/genetics\/158.4.1657","article-title":"Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans","volume":"158","author":"Smirnova","year":"2001","journal-title":"Genetics"},{"key":"10.1111\/bjd.12105-BIB18|cit18","doi-asserted-by":"crossref","first-page":"16645","DOI":"10.1073\/pnas.0704828104","article-title":"TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans","volume":"104","author":"Ferwerda","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/bjd.12105-BIB19|cit19","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1016\/j.ijid.2011.11.012","article-title":"Role of tumor necrosis factor gene single nucleotide polymorphisms in the natural course of 2009 influenza A H1N1 virus infection","volume":"16","author":"Antonopoulou","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1111\/bjd.12105-BIB20|cit20","first-page":"817","article-title":"The GA single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma","volume":"52","author":"O\u2019Keefe","year":"2002","journal-title":"J Trauma"},{"key":"10.1111\/bjd.12105-BIB21|cit21","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/jmg.2004.021600","article-title":"TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury","volume":"41","author":"Barber","year":"2004","journal-title":"J Med Genet"},{"key":"10.1111\/bjd.12105-BIB22|cit22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0007-1226(03)00177-2","article-title":"Hidradenitis suppurativa: pathogenesis and management","volume":"56","author":"Slade","year":"2003","journal-title":"Br J Plast Surg"},{"key":"10.1111\/bjd.12105-BIB23|cit23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2133.2003.05390.x","article-title":"Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa","volume":"149","author":"Sartorius","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12105-BIB24|cit24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000119108","article-title":"Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data","volume":"66","author":"Dudbridge","year":"2008","journal-title":"Hum Hered"},{"key":"10.1111\/bjd.12105-BIB25|cit25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2133.2007.07993.x","article-title":"Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population","volume":"157","author":"Nedoszytko","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12105-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1365-4632.2010.04465.x","article-title":"Human leukocyte antigen (HLA) and single nucleotide polymorphisms (SNPs) tumor necrosis factor (TNF)-alpha -238 and -308 as genetic markers of susceptibility to psoriasis and severity of the disease in a long-term follow-up Brazilian study","volume":"49","author":"Magalh\u00e3es","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12105-BIB27|cit27","first-page":"113","article-title":"A -308 promoter polymorphism of tumor necrosis factor alpha gene does not associate with the susceptibility to psoriasis vulgaris. No difference either between psoriasis type I and type II patients","volume":"15","author":"Baran","year":"2006","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"10.1111\/bjd.12105-BIB28|cit28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev-genom-082908-150013","article-title":"The genetics of Crohn\u2019s disease","volume":"10","author":"Van Limbergen","year":"2009","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1111\/bjd.12105-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1111\/j.1572-0241.2007.01463.x","article-title":"Has Toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association","volume":"102","author":"Browning","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/bjd.12105-BIB30|cit30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.gene.6364398","article-title":"The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases","volume":"8","author":"De Jager","year":"2007","journal-title":"Genes Immun"},{"key":"10.1111\/bjd.12105-BIB31|cit31","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ibd.20362","article-title":"Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn\u2019s disease in an Australian population","volume":"14","author":"Hume","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/bjd.12105-BIB32|cit32","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1365-2133.2005.07067.x","article-title":"Etanercept: effective in the management of hidradenitis suppurativa","volume":"154","author":"Cusack","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12105-BIB33|cit33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2133.2011.10339.x","article-title":"A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa","volume":"165","author":"Miller","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12105-BIB34|cit34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archdermatol.2010.72","article-title":"Treatment of hidradenitis suppurativa with etanercept injection","volume":"146","author":"Adams","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12105-BIB35|cit35","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1365-4632.2010.04545.x","article-title":"A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa","volume":"49","author":"Amano","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12105-BIB36|cit36","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaad.2006.07.027","article-title":"Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients","volume":"56","author":"Fardet","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12105-BIB37|cit37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/03009740600904284","article-title":"Tumour necrosis factor (TNF) alpha \u2212308\u2003G\/G promoter polymorphism and TNFalpha levels correlate with a better response to adalimumab in patients with rheumatoid arthritis","volume":"35","author":"Cuchacovich","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1111\/bjd.12105-BIB38|cit38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/sj.tpj.6500091","article-title":"Pharmacogenetic investigation of the TNF\/TNF-receptor system in patients with chronic active Crohn\u2019s disease treated with infliximab","volume":"2","author":"Mascheretti","year":"2002","journal-title":"Pharmacogenomics J"},{"key":"10.1111\/bjd.12105-BIB39|cit39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03256427","article-title":"Pharmacogenetic analysis of TNF, TNFRSF1A, and TNFRSF1B gene polymorphisms and prediction of response to anti-TNF therapy in psoriasis patients in the Greek population","volume":"16","author":"Vasilopoulos","year":"2012","journal-title":"Mol Diagn Ther"},{"key":"10.1111\/bjd.12105-BIB40|cit40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2133.2011.10698.x","article-title":"Adalimumab (antitumour necrosis factor-\u03b1) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study","volume":"166","author":"Van der Zee","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12105-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/j.1468-3083.2011.04338.x","article-title":"Single nucleotide polymorphisms of toll-like receptor-4 protect against acne conglobata","volume":"26","author":"Grech","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12105","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12105\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T21:01:45Z","timestamp":1714510905000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/168\/2\/311\/6614418"}},"subtitle":["Polymorphisms of<i>TLR4<\/i>and<i>TNF<\/i>genes in hidradenitis suppurativa"],"short-title":[],"issued":{"date-parts":[[2013,1,30]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12105","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,30]]}}}